Page 31 - Read Online

Chen et al. Plast Aesthet Res 2023;10:24 https://dx.doi.org/10.20517/2347-9264.2022.136 Page 21 of 26

31. Park JG, Yun HK, Ahn ST. The effect of radiation on the patency of end-to-side microvascular anastomosis. J Korean Soc Plast
Reconstr Surg 2001:565-570. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/wpr-70630 [Last accessed on 30 May
2023].
32. Barrera-Ochoa S, Gallardo-Calero I, López-Fernández A, et al. Effect of previous irradiation on vascular thrombosis of microsurgical
anastomosis: a preclinical study in rats. Plast Reconstr Surg Glob Open 2016;4:e1073. DOI PubMed PMC
33. Fracol ME, Basta MN, Nelson JA, et al. Bilateral free flap breast reconstruction after unilateral radiation: comparing intraoperative
vascular complications and postoperative outcomes in radiated versus nonradiated breasts. Ann Plast Surg 2016;76:311-4. DOI
34. Fosnot J, Fischer JP, Smartt JM Jr, et al. Does previous chest wall irradiation increase vascular complications in free autologous
breast reconstruction? Plast Reconstr Surg 2011;127:496-504. DOI
35. Rogers NE, Allen RJ. Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg
2002;109:1919-24. DOI PubMed
36. Tran NV, Chang DW, Gupta A, Kroll SS, Robb GL. Comparison of immediate and delayed free TRAM flap breast reconstruction in
patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 2001;108:78-82. DOI PubMed
37. Khavanin N, Yang JH, Colakoglu S, et al. Breast Reconstruction trends in the setting of postmastectomy radiation therapy: analysis
of practices among plastic surgeons in the United States. Plast Reconstr Surg Glob Open 2023;11:e4800. DOI PubMed PMC
38. Lee M, Reinertsen E, McClure E, et al. Surgeon motivations behind the timing of breast reconstruction in patients requiring
postmastectomy radiation therapy. J Plast Reconstr Aesthet Surg 2015;68:1536-42. DOI PubMed PMC
39. Baumann DP, Crosby MA, Selber JC, et al. Optimal timing of delayed free lower abdominal flap breast reconstruction after
postmastectomy radiation therapy. Plast Reconstr Surg 2011;127:1100-6. DOI
40. Meier CR, Jick H. Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 1998;45:608-12. DOI PubMed
PMC
41. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW, Hsu CY. Correlation of the tamoxifen use with the increased risk of deep vein
thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study. Medicine 2018;97:e12842. DOI
PubMed PMC
42. Decensi A, Maisonneuve P, Rotmensz N, et al; Italian Tamoxifen Study Group. Effect of tamoxifen on venous thromboembolic
events in a breast cancer prevention trial. Circulation 2005;111:650-6. DOI
43. Debbie Jiang, Alfred Ian Lee. Thrombotic Risk from Chemotherapy and Other Cancer Therapies. In: Soff G, editor. Thrombosis and
hemostasis in cancer. Cham: Springer International Publishing; 2019. pp. 87-101.
44. Kelley BP, Valero V, Yi M, Kronowitz SJ. Tamoxifen increases the risk of microvascular flap complications in patients undergoing
microvascular breast reconstruction. Plast Reconstr Surg 2012;129:305-14. DOI PubMed PMC
45. Jokuszies A, Radtke C, Betzler C, et al. Is tamoxifen associated with an increased risk for thromboembolic complications in patients
undergoing microvascular breast reconstruction? Ger Med Sci 2013;11:Doc05. DOI PubMed PMC
46. Parikh RP, Odom EB, Yu L, Colditz GA, Myckatyn TM. Complications and thromboembolic events associated with tamoxifen
therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis. Breast
Cancer Res Treat 2017;163:1-10. DOI PubMed PMC
47. Tran BNN, Ruan QZ, Cohen JB, et al. Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based
Microsurgical Breast Reconstruction? Plast Reconstr Surg 2018;141:805e-13e. DOI
48. Mirzabeigi MN, Nelson JA, Fischer JP, et al. Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as
potential perioperative thrombotic risk factors in free flap breast reconstruction. Plast Reconstr Surg 2015;135:670e-9e. DOI
49. Billon R, Bosc R, Belkacemi Y, et al. Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on
perioperative outcomes of breast reconstruction. J Plast Reconstr Aesthet Surg 2017;70:1495-504. DOI
50. Salibian AA, Bokarius AV, Gu J, et al. The effects of perioperative tamoxifen therapy on microvascular flap complications in
transverse rectus abdominis myocutaneous/deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg 2016;77:630-
4. DOI
51. Ritter EF, Cronan JC, Rudner AM, Serafin D, Klitzman B. Improved microsurgical anastomotic patency with low molecular weight
heparin. J Reconstr Microsurg 1998;14:331-6. DOI PubMed
52. Zhang B, Dougan P, Wieslander JB. A comparison of the early antithrombotic effects between low molecular weight heparin and
heparin in small arteries following a severe trauma: an experimental study. Ann Plast Surg 1993;31:255-61. DOI PubMed
53. Lighthall JG, Cain R, Wieslander TA, Wax MK. Effect of postoperative aspirin on outcomes in microvascular free tissue transfer
surgery. Otolaryngol Head Neck Surg 2013;148:40-6. DOI
54. Zhou W, Zhang WB, Yu Y, et al. Are antithrombotic agents necessary for head and neck microvascular surgery? Int J Oral
Maxillofac Surg 2019;48:869-74. DOI
55. Chen CM, Ashjian P, Disa JJ, et al. Is the use of intraoperative heparin safe? Plast Reconstr Surg 2008;121:49e-53e. DOI PubMed
56. Kroll SS, Miller MJ, Reece GP, et al. Anticoagulants and hematomas in free flap surgery. Plast Reconstr Surg 1995;96:643-7. DOI
57. Ashjian P, Chen CM, Pusic A, et al. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg
2007;59:36-9. DOI PubMed
58. Conrad MH, Adams WP Jr. Pharmacologic optimization of microsurgery in the new millennium. Plast Reconstr Surg
2001;108:2088-96. DOI PubMed
59. Stephan B, Schenk JF, Nemeh A, Pindur G. The use of antithrombotic agents in microvascular surgery. Clin Hemorheol Microcirc